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Crushing tablets and opening capsules before administration 
via nasogastric or enteral feeding tubes is a widespread 
practice. A survey of nursing homes in the UK reported that 
more than 80% crush tablets on at least a weekly basis, and 
40% of nurses crush tablets on every drug round.1 In hospitals 
in Queensland, Australia, 104 different drugs were recorded as 
being altered at the bedside, with 84% of the drugs altered on 
a daily basis;2 tablet crushing accounted for 75% of alterations.2 
However, data on the safety and efficacy of administering 
crushed tablets or opened capsules are limited. Patients may 
be harmed if the bioavailability of drugs is either impaired, 
resulting in reduced efficacy, or enhanced, resulting in toxicity. 
Mechanical failure of nasogastric tubes may also occur as 
a consequence of administering drugs. Finally, there are 
important medico-legal implications of administering altered 
oral drug formulations. 
This article highlights the problems associated with 
administering drugs via nasogastric or enteral feeding tubes, 
and suggests ways of improving the safety of this practice.
Altered absorption
Enteric-coated tablets protect the active ingredient against 
degradation by gastric acid, and crushing these tablets will 
reduce the bioavailability of the drug. For example, omeprazole 
is a lipophilic weak base that is unstable at a low pH and 
is formulated in a gelatin capsule containing small enteric-
coated granules that release the drug at a pH of >6.3 Crushing 
these granules will expose omeprazole to the acidic gastric 
contents, reducing its half-life to less than 10 minutes at a pH 
of <4.3 Some formulations, such as nitrates, may be sugar- or 
film-coated to protect against light and should therefore be 
administered immediately after being crushed. 
Erratic drug concentrations may be caused by crushing 
controlled-release drug formulations. Decreased bioavailability 
of a sustained-release formulation of theophylline, which 
is likely to reduce efficacy, was observed when it was 
crushed and administered via nasogastric tube.4  Enhanced 
bioavailability of a crushed sustained-release formulation of 
nifedipine has been demonstrated,5 which is likely to increase 
toxicity, graphically illustrated by a case report of fatal cardiac 
arrest after a patient received crushed sustained-release 
nifedipine.6 
Drug-enteral feed interaction
Flushing crushed tablets down the nasogastric tube with 
enteral feeds is a common nursing practice that may cause 
sub-therapeutic concentrations if the administered drug binds 
to the feed. Serum concentrations of phenytoin are reduced 
by 72% when it is administered with enteral feeds.7 Phenytoin 
binds strongly to serum proteins, and it is thought that the 
decreased absorption of this drug when it is given with enteral 
feeds may be caused by binding to proteins in the feed. The 
bioavailability of crushed ciprofloxacin is also markedly 
reduced when it is co-administered with enteral feed,8 
probably owing to ciprofloxacin binding to divalent cations.9 
Enteral feeds should be withheld for 2 hours before and after 
administering drugs known to interact with feeds. 
Mechanics of crushing – interactions 
and hypersensitivity
Crushing different medications in the same receptacle should 
be avoided owing to possible drug interactions. For example, 
the bioavailability of tetracycline is decreased when it is 
crushed together with iron supplements because of formation 
of poorly soluble tetracycline-iron chelates.10 
It is important to clean the pestle and mortar properly before 
crushing tablets for the next patient to prevent hypersensitivity 
reactions, which may be triggered after exposure to a small 
amount of the drug allergen.
Binding to the nasogastric tube 
Nasogastric tubes are made of polyvinyl chloride, and certain 
drugs (e.g. phenytoin11 and carbamazepine suspensions,12 
and levothyroxine13 and amiodarone tablets14) have been 
shown to bind to the wall of the nasogastric tube. Diluting 
the administered drug and irrigating afterwards with water, 
sodium chloride or dextrose will decrease binding to the tube.12 
Tube occlusion 
Administering crushed medication via a nasogastric tube 
may occlude the tube. Bulk-forming laxatives, such as 
ispaghula, form a semi-solid mass that may occlude the 
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tube.9 Cholestyramine, a bile acid sequestrant, and crushed 
gelatin-coated capsules, such as omeprazole, may also occlude 
nasogastric tubes.15 Various approaches have been used to clear 
blocked tubes, but there is no evidence that any of these are 
more effective than flushing with water.15 
Rate of gastric emptying
Gastric emptying may be delayed in critically ill or 
postoperative patients who require nasogastric tubes. Delayed 
gastric emptying will reduce the bioavailability of drugs that 
are either crushed and administered via nasogastric tube or 
taken orally. Paracetamol16 and atenolol17 were demonstrated to 
have significantly reduced bioavailability when administered 
as crushed formulations via nasogastric tube postoperatively 
compared with intact tablets preoperatively.
Medico-legal implications
Drugs are registered to be administered as particular 
formulations, and altering the formulation before 
administration renders their use off-label. Consequently the 
manufacturer will assume no responsibility for any harm 
caused to the patient by crushing tablets.1 To minimise liability, 
the reasons why dose modification needed to be made should 
be clearly documented. Ideally evidence-based practice should 
be followed, but there are data supporting the safety of only 
very few drugs (e.g. antituberculosis drugs,18,19 fluconazole,20 
linezolid21 and moxifloxacin22). Importantly, nursing staff 
should not administer crushed tablets without authorisation, 
which is the responsibility of the prescriber. Despite the fact 
that unauthorised crushing of tablets exposes nursing staff to 
litigation, a study looking at medication errors in psychiatric 
inpatients found that unauthorised crushing was the 
commonest error encountered.23 More worrying is the fact that 
9.8% of nurses surveyed in nursing homes in the UK would not 
seek advice before crushing tablets.1
Guidelines for safer practices
Table I lists safer practices for administering drugs to patients 
with nasogastric or enteral feeding tubes. 
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Table I. Guide to safer administration of drugs via 
nasogastric tubes
General considerations
•  Consider alternative routes of administration (e.g. rectal, 
subcutaneous, intramuscular) 
•  It is preferable to use commercially available suspensions 
rather than crushing tablets or opening capsules
•  Consult a pharmacist or clinical pharmacologist
•  Nurses should not crush tablets/open capsules without the 
authorisation of the prescriber
Enteral feed and tube management
•  Stop the enteral feed and flush the tube with at least 30 ml 
water before administering the drug 
•  Flush between drugs with at least 10 ml water to ensure that 
the drug is cleared from the tube 
•  Withhold enteral feeds for 2 hours before and after drug 
administration for drugs with known interactions with feeds 
Mechanics of crushing
•  Use a porcelain or glass (not wooden) pestle and mortar to 
crush the drugs
• Do not crush different drugs together
•  Mix the crushed drugs with 10 - 15 ml water to facilitate 
administration
•  Thoroughly clean the pestle and mortar between different 
patients
Formulation-specific recommendations
•  Soluble tablets. Dissolve in 10 - 15 ml water
•  Liquids/suspensions. Dilute viscous liquids with an equal 
amount of water before administration
•  Tablets. Do not crush enteric-coated or modified-release drugs. 
Mix with 10 - 15 ml water
•  Capsules. If the capsule content is viscous, prick and squeeze 
contents into receptacle and mix with water
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